文献速递食管与纵隔外科

手术方式影响生存吗?机器人、微创与开放食管切除术的生存比较

Does the Approach Matter? Comparing Survival in Robotic, Minimally Invasive, and Open Esophagectomies.
PubMed 文献 · Ann Thorac Surg · 2018-10-09

基于美国国家癌症数据库2010至2015年病理分期0至III期食管癌患者,比较机器人辅助微创食管切除术(RAMIE)、微创食管切除术(MIE)与开放食管切除术(OE)的生存与术后结局。共纳入5553例,经倾向性评分匹配后,MIE和RAMIE的生存与OE相当,RAMIE显示生存获益趋势,且两种微创方式淋巴结清扫数显著更高。

要点

  • MIE和RAMIE的长期生存不劣于开放食管切除术。
  • RAMIE与MIE的淋巴结清扫数显著高于开放手术。
  • 微创方式住院时间更短,30天再入院及30/90天死亡率无差异。

核心结论

  • 微创食管切除术(MIE和RAMIE)的长期生存结果不劣于开放食管切除术,且淋巴结清扫数更高。
  • MIE使用趋势已超过开放手术,微创方式正成为首选。

研究设计与样本

  • 回顾性队列研究,查询美国国家癌症数据库2010至2015年病理分期0至III期食管癌患者。
  • 共纳入5553例患者,其中MIE占28.4%,RAMIE占7.8%,OE占63.8%;手术组间进行1:1倾向性评分匹配。
  • 主要结局包括住院时间、30天非计划再入院、30天和90天死亡率及总生存率;采用Kaplan-Meier法和Cox比例风险回归分析。

主要发现

  • 30天非计划再入院及30天和90天死亡率在各组间无显著差异。
  • MIE和RAMIE的中位住院时间均为9天,显著短于OE的10天(p < 0.001)。
  • 倾向性评分匹配后,MIE和RAMIE与OE的中位总生存估计无显著差异(log-rank p = 0.603)。
  • MIE调整后风险比为0.97(95%CI 0.89至1.06;p = 0.530),RAMIE风险比为0.81(95%CI 0.69至0.95;p = 0.012)。
  • 中位淋巴结清扫数:MIE 15枚(IQR 9至22),RAMIE 17枚(IQR 11至24),OE 13枚(IQR 8至20)。

临床怎么用

  • 在适合的患者中,可优先考虑MIE或RAMIE,因其生存不劣于开放手术且住院时间更短。
  • RAMIE可能提供更高的淋巴结清扫数,有助于术后准确分期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Our objective was to determine how surgical approach impacts overall survival and postoperative outcomes when comparing robotic-assisted minimally invasive esophagectomy (RAMIE), minimally invasive esophagectomy (MIE), and open esophagectomy (OE). METHODS: The National Cancer Database was queried for patients diagnosed with pathologic Stage 0 to III esophageal cancer from 2010 to 2015. Primary outcome measures evaluated were length of stay, 30-day unplanned readmissions, mortality rates at 30 and 90 days, and overall survival rates. The surgical cohorts underwent 1:1 propensity score matching, and Kaplan-Meier survival estimates were compared by surgical approach. Cox proportional hazards regression was utilized to estimate factors associated with overall survival. RESULTS: Of 5,553 patients that met criteria, 28.4% were MIE, 7.8% RAMIE, and 63.8% OE. From 2010 to 2015, an increasing trend was seen for both minimally invasive approaches, with MIE surpassing the number of OEs. Unplanned 30-day readmissions and 30-day and 90-day mortality rates were not significantly different between the different groups. Median length of stay was significantly shorter in MIE (9 [interquartile range (IQR), 8 to 14] days) and RAMIE (9 [IQR, 7 to 14] days), compared with OE (10 [IQR, 8 to 15] days; p < 0.001). MIE and RAMIE had comparable survival rates compared with OE, with no significant differences in median overall survival estimates after propensity score matching (log-rank p = 0.603), with a trend for increased survival in MIE (adjusted hazard ratio, 0.97; 95% confidence interval, 0.89 to 1.06; p = 0.530) and RAMIE (hazard ratio, 0.81; 95% confidence interval, 0.69 to 0.95; p = 0.012). Both minimally invasive approaches had a significantly higher median lymph node counts (MIE: 15 [IQR, 9 to 22]; RAMIE: 17 [IQR, 11 to 24]; OE: 13 [IQR, 8 to 20]), which may highlight important differences in postoperative upstaging. CONCLUSIONS: Trends in MIE use is surpassing the open approach. Minimally invasive approaches are becoming the preferred approach, with noninferior long-term results compared with OEs. A significantly higher lymph node yield was seen for RAMIE and MIE.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Espinoza-Mercado F, Imai TA, Borgella JD, et al. Does the Approach Matter? Comparing Survival in Robotic, Minimally Invasive, and Open Esophagectomies. Ann Thorac Surg. 2018. PMID: 30312615. doi:10.1016/j.athoracsur.2018.08.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。